Clinical Trials
277
Active:6
Completed:37
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:13
Phase 2:16
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (178 trials with phase data)• Click on a phase to view related trials
Not Applicable
131 (73.6%)Phase 2
16 (9.0%)Phase 1
13 (7.3%)Phase 4
8 (4.5%)Early Phase 1
5 (2.8%)Phase 3
5 (2.8%)Biomarker-based Alzheimer's Disease Cohort Study (BASIC)
Recruiting
- Conditions
- Alzheimer Disease
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 2835
- Registration Number
- NCT07109999
- Locations
- 🇨🇳
Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China
An Application Provides Personalized Suggestions Based on Secondary Prevention Risk Factors to Stroke Patients
Not Applicable
Not yet recruiting
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 5092
- Registration Number
- NCT07098143
An Application Provides Temperature-related Health Risk Warnings and Protective Recommendations on Stroke
Not Applicable
Not yet recruiting
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 5092
- Registration Number
- NCT07097428
The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 5
- Registration Number
- NCT07095933
- Locations
- 🇨🇳
Xuanwu Hospital, Beijing, Beijing, Beijing, China
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Not Applicable
Recruiting
- Conditions
- Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous SystemMS (Multiple Sclerosis)NMOSDAcute Disseminated EncephalomyelitisTranscranial Alternating Current Stimulation
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Target Recruit Count
- 128
- Registration Number
- NCT07087873
- Locations
- 🇨🇳
Xuanwu Hospital, Capital Medical University, Beijing, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 56
- Next
News
No news found